| Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers M Rozenblit, R Huang, N Danziger, P Hegde, B Alexander, S Ramkissoon, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 108 | 2020 |
| A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases RSP Huang, J Haberberger, E Severson, DL Duncan, A Hemmerich, ... Modern Pathology 34 (2), 252-263, 2021 | 100 | 2021 |
| Performance of the Verigene® enteric pathogens test, Biofire FilmArray™ gastrointestinal panel and Luminex xTAG® gastrointestinal pathogen panel for detection of common … RSP Huang, CL Johnson, L Pritchard, R Hepler, TT Ton, JJ Dunn Diagnostic Microbiology and Infectious Disease 86 (4), 336-339, 2016 | 96 | 2016 |
| Microbiology and molecular diagnosis in pathology: a comprehensive review for board preparation, certification and clinical practice A Wanger, V Chavez, R Huang, A Wahed, A Dasgupta, JK Actor Elsevier, 2017 | 89 | 2017 |
| Predictive biomarkers for immune checkpoint inhibitors in metastatic breast cancer A Sivapiragasam, P Ashok Kumar, ES Sokol, LA Albacker, JK Killian, ... Cancer medicine 10 (1), 53-61, 2021 | 45 | 2021 |
| Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss DI Lin, A Hemmerich, C Edgerly, D Duncan, EA Severson, RSP Huang, ... Gynecologic Oncology 157 (2), 357-366, 2020 | 45 | 2020 |
| Identification and utilization of biomarkers to predict response to immune checkpoint inhibitors O Gjoerup, CA Brown, JS Ross, RSP Huang, A Schrock, J Creeden, ... The AAPS Journal 22, 1-15, 2020 | 44 | 2020 |
| Comprehensive assessment of immuno-oncology biomarkers in adenocarcinoma, urothelial carcinoma, and squamous-cell carcinoma of the bladder A Necchi, R Madison, D Raggi, JM Jacob, G Bratslavsky, O Shapiro, ... European Urology 77 (4), 548-556, 2020 | 44 | 2020 |
| Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer MK Moutafi, W Tao, R Huang, J Haberberger, B Alexander, S Ramkissoon, ... Journal for immunotherapy of cancer 9 (4), 2021 | 34 | 2021 |
| Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization RSP Huang, D Smith, CH Le, WW Liu, E Ordinario, C Manohar, M Lee, ... Archives of pathology & laboratory medicine 144 (6), 735-741, 2020 | 32 | 2020 |
| Study of preanalytic and analytic variables for clinical next-generation sequencing of circulating cell-free nucleic acid M Mehrotra, RR Singh, W Chen, RSP Huang, AA Almohammedsalim, ... The Journal of Molecular Diagnostics 19 (4), 514-524, 2017 | 27 | 2017 |
| Antibiotics, antimicrobial resistance, antibiotic susceptibility testing, and therapeutic drug monitoring for selected drugs A Wanger, V Chavez, RSP Huang, A Wahed, JK Actor, A Dasgupta Microbiology and molecular diagnosis in pathology, 119-153, 2017 | 27 | 2017 |
| Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian origin DI Lin, N Shah, YT Julie, JK Killian, A Hemmerich, C Edgerly, ... Gynecologic Oncology Reports 34, 100652, 2020 | 26 | 2020 |
| Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma RSP Huang, J Haberberger, K Murugesan, N Danziger, M Hiemenz, ... Modern Pathology 34 (7), 1425-1433, 2021 | 25 | 2021 |
| Clinicopathologic and genomic landscape of breast carcinoma brain metastases RSP Huang, J Haberberger, K McGregor, DA Mata, B Decker, ... The Oncologist 26 (10), 835-844, 2021 | 23 | 2021 |
| Post-operative bleeding risk stratification in cardiac pulmonary bypass patients using artificial neural network RSP Huang, E Nedelcu, Y Bai, A Wahed, K Klein, H Tint, I Gregoric, ... Annals of Clinical & Laboratory Science 45 (2), 181-186, 2015 | 21 | 2015 |
| Pan-cancer landscape of CD274 (PD-L1) copy number changes in 244 584 patient samples and the correlation with PD-L1 protein expression RSP Huang, K Murugesan, M Montesion, DC Pavlick, DA Mata, ... Journal for Immunotherapy of Cancer 9 (5), 2021 | 20 | 2021 |
| Delta-like protein 3 prevalence in small cell lung cancer and DLL3 (SP347) assay characteristics RSP Huang, BF Holmes, C Powell, RV Marati, D Tyree, B Admire, ... Archives of pathology & laboratory medicine 143 (11), 1373-1377, 2019 | 20 | 2019 |
| Heterotopic ossification in metastatic colorectal carcinoma: case report with morphoproteomic insights into the histogenesis RSP Huang, RE Brown, J Buryanek Annals of Clinical & Laboratory Science 44 (1), 99-103, 2014 | 20 | 2014 |
| Biomarkers in breast cancer: An integrated analysis of comprehensive genomic profiling and Pd‐L1 immunohistochemistry biomarkers in 312 patients with breast cancer RSP Huang, X Li, J Haberberger, E Sokol, E Severson, DL Duncan, ... The oncologist 25 (11), 943-953, 2020 | 19 | 2020 |
